Syphilis Testing Market Expected to Reach $1.9 Billion by 2030 | Allied Market Research

Syphilis testing is a crucial component of the diagnosis, treatment, and prevention of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. Testing for syphilis involves the detection of antibodies produced by the body in response to the infection. The global syphilis testing market size was valued at $1.1 billion in 2020, and is projected to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.

✦ Download Sample Copy of Report -

https://www.alliedmarketresearch.com/request-sample/675

There are several types of syphilis tests available, including non-treponemal tests and treponemal tests. Non-treponemal tests, such as the Venereal Disease Research Laboratory (VDRL) and Rapid Plasma Reagin (RPR) tests, detect antibodies that react with a substance derived from T. pallidum. These tests are used for screening and monitoring the progression of the disease. However, false-positive results can occur, requiring confirmation with treponemal tests.

Treponemal tests, such as the Fluorescent Treponemal Antibody Absorption (FTA-ABS) test and the Treponema pallidum Particle Agglutination (TP-PA) assay, directly detect antibodies against T. pallidum. These tests are highly specific and used to confirm syphilis infection.

Top Key Companies Included in Exclusive Report -

Bio-Rad Laboratories, Cepheid Inc., siemens healthcare, beckman coulter, Hologic, Inc., DiaSorin, F. Hoffmann-La Roche, Affymetrix, Inc, Becton Dickinson And Company, Abbott Laboratories

✦ Procure Complete Report at 20% Discount (200 Pages) -

https://www.alliedmarketresearch.com/syphilis-testing-market/purchase-options

In recent years, advancements in technology have led to the development of rapid point-of-care tests (POCT) for syphilis. These tests provide quick and convenient results within minutes, making them valuable tools for screening and diagnosis in resource-limited settings.

Syphilis testing is important not only for individual diagnosis and treatment but also for public health surveillance and prevention efforts. Early detection and treatment of syphilis can prevent the progression of the disease, reduce complications, and help prevent transmission to sexual partners or from mother to child during pregnancy.

It is crucial for healthcare providers to follow established testing algorithms and guidelines when screening and diagnosing syphilis. Additionally, regular testing for syphilis is recommended for individuals at high risk, including those with multiple sexual partners, men who have sex with men, and pregnant women, as part of comprehensive sexual health care.

✦ Speak with Analyst -

https://www.alliedmarketresearch.com/connect-to-analyst/675

✅ 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐈𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 -

Prefilled Syringes Market - https://www.alliedmarketresearch.com/prefilled-syringes-market  

Photomedicine Market - https://www.alliedmarketresearch.com/photomedicine-market  

Sleep Aids Market - https://www.alliedmarketresearch.com/sleep-aids-market  

HIV Drugs Market - https://www.alliedmarketresearch.com/hiv-drugs-market  

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com